These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15975254)

  • 21. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.
    Concheiro M; Shakleya DM; Huestis MA
    Forensic Sci Int; 2009 Jul; 188(1-3):144-51. PubMed ID: 19406593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry.
    Grimm D; Pauly E; Pöschl J; Linderkamp O; Skopp G
    Ther Drug Monit; 2005 Aug; 27(4):526-30. PubMed ID: 16044112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of nonhydrolysis and hydrolysis methods for the determination of buprenorphine metabolites in urine by liquid chromatography-tandem mass spectrometry.
    Al-Asmari AI; Anderson RA
    J Anal Toxicol; 2008; 32(9):744-53. PubMed ID: 19021929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry.
    Kronstrand R; Seldén TG; Josefsson M
    J Anal Toxicol; 2003 Oct; 27(7):464-70. PubMed ID: 14607001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of buprenorphine, naloxone and phase I and phase II metabolites in rat whole blood by LC-MS/MS.
    Cohier C; Salle S; Fontova A; Mégarbane B; Roussel O
    J Pharm Biomed Anal; 2020 Feb; 180():113042. PubMed ID: 31865207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gas chromatographic-mass spectrometric quantitation of urinary buprenorphine and norbuprenorphine after derivatization by direct extractive alkylation.
    Lisi AM; Kazlauskas R; Trout GJ
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):67-77. PubMed ID: 9187385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.
    Concheiro M; Jones H; Johnson RE; Shakleya DM; Huestis MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):13-20. PubMed ID: 19945361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined liquid chromatography-coulometric detection and microextraction by packed sorbent for the plasma analysis of long acting opioids in heroin addicted patients.
    Somaini L; Saracino MA; Marcheselli C; Zanchini S; Gerra G; Raggi MA
    Anal Chim Acta; 2011 Sep; 702(2):280-7. PubMed ID: 21839210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of buprenorphine in rat plasma using a solid-phase extraction technique and high-performance liquid chromatography with electrochemical detection.
    Salem A; Pierce TL; Hope W
    J Pharmacol Toxicol Methods; 1997 Mar; 37(2):75-81. PubMed ID: 9174982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes.
    Oechsler S; Skopp G
    Forensic Sci Int; 2010 Feb; 195(1-3):73-7. PubMed ID: 20006453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis).
    Belsey SL; Couchman L; Flanagan RJ
    J Anal Toxicol; 2014 Sep; 38(7):438-43. PubMed ID: 24925983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry.
    Rodriguez-Rosas ME; Lofwall MR; Strain EC; Siluk D; Wainer IW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):538-43. PubMed ID: 17141582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.
    Kuhlman JJ; Levine B; Johnson RE; Fudala PJ; Cone EJ
    Addiction; 1998 Apr; 93(4):549-59. PubMed ID: 9684393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
    Tzatzarakis MN; Vakonaki E; Kovatsi L; Belivanis S; Mantsi M; Alegakis A; Liesivuori J; Tsatsakis AM
    J Anal Toxicol; 2015 May; 39(4):313-20. PubMed ID: 25663675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.
    Valiveti S; Nalluri BN; Hammell DC; Paudel KS; Stinchcomb AL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):259-67. PubMed ID: 15380723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry.
    Fang WB; Chang Y; McCance-Katz EF; Moody DE
    J Anal Toxicol; 2009 Oct; 33(8):409-17. PubMed ID: 19874646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.
    Liu W; Cai HL; Li HD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):405-11. PubMed ID: 17222591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Column-switching solid-phase trace-enrichment high-performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detection.
    Schleyer E; Lohmann R; Rolf C; Gralow A; Kaufmann CC; Unterhalt M; Hiddemann W
    J Chromatogr; 1993 May; 614(2):275-83. PubMed ID: 8314940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of buprenorphine and norbuprenorphine in urine using liquid chromatography tandem mass spectrometry.
    Fox EJ; Tetlow VA; Allen KR
    J Anal Toxicol; 2006 May; 30(4):238-44. PubMed ID: 16803661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.